Marcelle Layton

5.0k total citations · 3 hit papers
6 papers, 3.6k citations indexed

About

Marcelle Layton is a scholar working on Public Health, Environmental and Occupational Health, Endocrinology and Molecular Biology. According to data from OpenAlex, Marcelle Layton has authored 6 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Public Health, Environmental and Occupational Health, 3 papers in Endocrinology and 2 papers in Molecular Biology. Recurrent topics in Marcelle Layton's work include Diphtheria, Corynebacterium, and Tetanus (2 papers), Bacillus and Francisella bacterial research (2 papers) and Poxvirus research and outbreaks (2 papers). Marcelle Layton is often cited by papers focused on Diphtheria, Corynebacterium, and Tetanus (2 papers), Bacillus and Francisella bacterial research (2 papers) and Poxvirus research and outbreaks (2 papers). Marcelle Layton collaborates with scholars based in United States and United Kingdom. Marcelle Layton's co-authors include Michael T. Osterholm, Thomas V. Inglesby, Trish M. Perl, Jerome Hauer, John G. Bartlett, Kevin Tonat, Gerald Parker, Edward M. Eitzen, Michael S. Ascher and Philip K. Russell and has published in prestigious journals such as JAMA, Clinical Infectious Diseases and Current Opinion in Infectious Diseases.

In The Last Decade

Marcelle Layton

6 papers receiving 3.5k citations

Hit Papers

Botulinum Toxin as a Biological Weapon 1999 2026 2008 2017 2001 1999 2001 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Botulinum Toxin as a Biological Weapon
    2001 1.3k citations S. S. Arnon, Robert Schechter et al. JAMA profile →
  2. Smallpox as a Biological Weapon
    1999 1.2k citations Thomas V. Inglesby, John G. Bartlett et al. JAMA profile →
  3. Tularemia as a Biological Weapon
    2001 1.0k citations David T. Dennis, Thomas V. Inglesby et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcelle Layton United States 5 2.3k 1.3k 925 770 718 6 3.6k
Anne D. Fine United States 12 1.9k 0.8× 1.3k 1.0× 920 1.0× 439 0.6× 727 1.0× 18 3.7k
Conrad P. Quinn United States 38 2.5k 1.1× 1.0k 0.8× 241 0.3× 376 0.5× 750 1.0× 92 3.2k
M. Louise M. Pitt United States 34 2.1k 0.9× 1.2k 0.9× 48 0.1× 324 0.4× 1.5k 2.0× 80 3.7k
Catharine M. Bosio United States 33 2.6k 1.1× 1.1k 0.8× 73 0.1× 440 0.6× 2.2k 3.0× 93 5.2k
Z. A. McGee United States 30 785 0.3× 503 0.4× 32 0.0× 125 0.2× 1.0k 1.4× 82 3.7k
Carolina B. López United States 40 1.1k 0.5× 374 0.3× 44 0.0× 289 0.4× 1.0k 1.5× 106 4.7k
Sonja M. Best United States 36 586 0.3× 444 0.4× 116 0.1× 299 0.4× 2.7k 3.7× 84 4.1k
Craig Martens United States 30 1.0k 0.4× 422 0.3× 129 0.1× 597 0.8× 1.5k 2.1× 109 3.6k
Peter J. Bredenbeek Netherlands 29 1.0k 0.5× 465 0.4× 68 0.1× 164 0.2× 2.8k 3.9× 49 4.3k
Eric T. Harvill United States 37 1.2k 0.5× 652 0.5× 138 0.1× 27 0.0× 580 0.8× 142 4.2k

Countries citing papers authored by Marcelle Layton

Since Specialization
Citations

This map shows the geographic impact of Marcelle Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelle Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelle Layton more than expected).

Fields of papers citing papers by Marcelle Layton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelle Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelle Layton. The network helps show where Marcelle Layton may publish in the future.

Co-authorship network of co-authors of Marcelle Layton

This figure shows the co-authorship network connecting the top 25 collaborators of Marcelle Layton. A scholar is included among the top collaborators of Marcelle Layton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelle Layton. Marcelle Layton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Arnon, Stephen S., Robert Schechter, Thomas V. Inglesby, et al.. (2001). Botulinum toxin as a biological weapon. JAMA. 285(8). 95 indexed citations
2.
O’Toole, Tara, et al.. (2001). Lessons from the West Nile Viral Encephalitis Outbreak in New York City, 1999: Implications for Bioterrorism Preparedness. Clinical Infectious Diseases. 32(2). 277–282. 56 indexed citations
3.
Dennis, David T., Thomas V. Inglesby, John G. Bartlett, et al.. (2001). Tularemia as a Biological Weapon. JAMA. 285(21). 2763–2763. 1020 indexed citations breakdown →
4.
Arnon, S. S., Robert Schechter, Thomas V. Inglesby, et al.. (2001). Botulinum Toxin as a Biological Weapon. JAMA. 285(8). 1059–1059. 1297 indexed citations breakdown →
5.
Inglesby, Thomas V., John G. Bartlett, Michael S. Ascher, et al.. (1999). Smallpox as a Biological Weapon. JAMA. 281(22). 2127–2127. 1179 indexed citations breakdown →
6.
Layton, Marcelle & Frank J. Bia. (1992). Emerging issues in travel medicine. Current Opinion in Infectious Diseases. 5(3). 338–344. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne D. Fine Breakdown of academic impact, for papers by Conrad P. Quinn Breakdown of academic impact, for papers by M. Louise M. Pitt Breakdown of academic impact, for papers by Catharine M. Bosio Breakdown of academic impact, for papers by Z. A. McGee Breakdown of academic impact, for papers by Carolina B. López Breakdown of academic impact, for papers by Sonja M. Best Breakdown of academic impact, for papers by Craig Martens Breakdown of academic impact, for papers by Peter J. Bredenbeek Breakdown of academic impact, for papers by Eric T. Harvill
Rankless by CCL
2026